1 High-Yielding Vanguard ETF That Has Trounced the Market This Year
https://www.fool.com/investing/2024/10/11/1-high-yielding-vanguard-etf-that-has-trounced-the/?source=iedfolrf0000001
Oct 11, 2024 - Investing in utility stocks could make for an underrated growth opportunity.
0
This Incredibly Cheap Tech Stock Has Jumped 20% in 3 Months, and Artificial Intelligence (AI) Could Become a Game Changer for It
https://www.fool.com/investing/2024/10/11/this-incredibly-cheap-tech-stock-has-jumped-20-in/?source=iedfolrf0000001
Oct 11, 2024 - This company's integration of AI tools into its offerings could lead to stronger growth in the long run.
0
Former Monkee has plenty of stories to tell
https://www.ocregister.com/2024/10/10/former-monkee-has-plenty-of-stories-to-tell/
Oct 10, 2024 - Micky Dolenz will be performing "An Evening of Songs and Stories" in Laguna Woods on Oct. 11
0
How RB Woody Marks, a ‘once-in-a-lifetime kid,’ has become the heartbeat of USC’s offense
https://www.ocregister.com/2024/10/10/how-rb-woody-marks-a-once-in-a-lifetime-kid-has-become-the-heartbeat-of-uscs-offense/
Oct 10, 2024 - Marks once endeared himself to Mississippi State’s Mike Leach, who called him “tougher than boot leather,” and now has endeared himself to Leach’s disciple Lincoln Riley.
0
BioMarin resumed at Raymond James at outperform as stock price has hit floor
https://seekingalpha.com/news/4157678-biomarin-resumed-raymond-james-outperform-stock-price-has-hit-floor?source=feed_sector_healthcare
Oct 10, 2024 - Raymond James reinstatess coverage of BioMarin Pharmaceutical with an outperform rating, seeing strong revenue potential despite competition for Voxzogo. Read more here.
0
As Sunrun's Debt Grows, The Company Has A Profitability Problem
https://seekingalpha.com/article/4725903-as-sunruns-debt-grows-company-has-a-profitability-problem?source=feed_all_articles
Oct 09, 2024 - Sunrun faces risks from its heavy debt load and the solar industry's emerging nature. See more about RUN stock and the profitability challenges ahead.
0
Ocugen says the FDA has removed the clinical hold on the eye drug OCU200
https://seekingalpha.com/news/4157325-ocugen-says-fda-has-removed-clinical-hold-on-eye-drug-ocu200?source=feed_sector_healthcare
Oct 09, 2024 - Ocugen (OCGN) said the FDA has removed a clinical hold on its IND application for a Phase 1 study evaluating its drug candidate OCU200 in the treatment of diabetic macular edema.
0
Peru has attracted a slew of foreign investors into its credit market. Here's why
https://www.cnbc.com/2024/10/08/peru-has-attracted-a-slew-of-foreign-investors-into-its-credit-market-heres-why.html
Oct 08, 2024 - Foreign investors are eyeing Peru's debt market.
0
CareDx says DOJ has closed investigation, no wrongdoing found
https://seekingalpha.com/news/4157046-caredx-says-doj-has-closed-investigation-no-wrongdoing-found?source=feed_sector_healthcare
Oct 08, 2024 - CareDx (CDNA) said the U.S. Department of Justice has closed its investigation into the company with no finding of wrongdoing. Read more here.
0
FFA: This Fund Has Become Even More Concentrated In Tech
https://seekingalpha.com/article/4725617-ffa-even-more-concentrated-in-tech?source=feed_tag_etf_portfolio_strategy
Oct 08, 2024 - First Trust Enhanced Equity Income Fund offers a 7.00% yield through a covered call strategy, but its yield is lower than some peers. Read more on FFA CEF here.
0